Tag: time

MUMBAI, India, June 16, 2026 /PRNewswire/ -- InCred Capital, the institutional, wealth and asset management arm of InCred Group, today announced the launch of...

REYKJAVIK, Iceland , June 16, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the pricing of its previously announced underwritten public offering (the “Offering”) of 22,666,667 of its ordinary shares at an offering price of $3.75 per share. All ordinary shares to be sold in the Offering will be offered by Alvotech. The Offering is expected to close on or about June 17, 2026, subject to satisfaction of customary closing conditions. The Company has also granted the underwriters a 30-day option to purchase up to an additional 3,400,000 ordinary shares at the public offering price, less underwriting discounts and commissions. Before deducting the underwriting discounts and commissions and offering expenses, the Company expects to receive total gross proceeds of approximately $85 million from the Offering, or approximately $98 million if the underwriters exercise in full their option to purchase additional shares.

Rhode Island Becomes Zum's 18th State as Company Expands Northeast PresenceREDWOOD CITY, Calif., June 15, 2026 /PRNewswire/ -- Scituate School Department and Johnston Public...

MORGANTOWN, W.Va., June 15, 2026 /PRNewswire/ -- Prominently featured in The Inner Circle, Haider Jaffrey, DDS is acknowledged as a Pinnacle Lifetime Member for his...

NEW YORK, June 15, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Regencell Bioscience Holdings Limited (NASDAQ: RGC) between October 28, 2024 and October 31, 2025, inclusive (the “Class Period”), of the important June 23, 2026 lead plaintiff deadline.

AI strategies automatically execute trades, with XRP settling daily on time, completely eliminating the need for manual monitoring.

AI strategies automatically execute trades, with XRP settling daily on time, completely eliminating the need for manual monitoring.

Functional ingredient innovator outpaces supplement industry growth through proprietary ingredient development, fermentation technology, and expanding global partnershipsBOISE, Idaho, June 15, 2026 /PRNewswire/ -- NNB Nutrition,...

MONTREAL, June 15, 2026 /CNW/ -- Tecsys Inc. (TSX: TCS) will release its financial results for the fourth quarter and fiscal year 2026 ended April...

An immersive pop-up experience invites guests to discover the delicious possibilities of Lifeway Kefir through custom smoothies, exclusive merchandise and special surprisesAn exclusive first...

NEW YORK, June 15, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of PennyMac Financial Services, Inc. (NYSE: PFSI) resulting from allegations that PennyMac may have issued materially misleading business information to the investing public.

DERM Zero is a world-first - using Class III regulated medical device1 technology to deliver autonomous clinical grade skin cancer assessments from a standard...

"Data and the Beast: The Truth About Data Centers and AI" — a prophetic and investigative exposé that connects the explosive growth of AI...

VANCOUVER, BC, June 15, 2026 /CNW/ - Lundin Gold Inc. (TSX: LUG) (Nasdaq Stockholm: LUG) (OTCQX: LUGDF) ("Lundin Gold" or the "Company") announces an...

Terra Innovatum Global N.V. (NASDAQ: NKLR) Files 2025 Form 10‑k and Reports Fourth Quarter and Fiscal Year 2025 Financial Results